ARCHIVES

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

This article is from The Cancer Letter archive.

Vol. 20 No. 38 | October 7, 1994

Download PDF Visit The Full Archive

Related Articles

Tempero, Johnson To Lead ASCO

March 28, 2003

Voluntary Organizations: ACS Board Approves Prostate Cancer Funding Set-Asides

November 15, 1996

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.

March 30, 2001

NIH Revises Application Receipt Dates

November 22, 1985

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004